These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 31504352)
41. Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment. Lin XJ; Lao XM; Shi M; Li SP Dig Dis Sci; 2016 Sep; 61(9):2465-76. PubMed ID: 27105647 [TBL] [Abstract][Full Text] [Related]
42. Prevention of hepatocellular carcinoma in hepatitis B virus infection. Lim SG; Mohammed R; Yuen MF; Kao JH J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903 [TBL] [Abstract][Full Text] [Related]
43. Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience. Chen VL; Yeh ML; Le AK; Jun M; Saeed WK; Yang JD; Huang CF; Lee HY; Tsai PC; Lee MH; Giama N; Kim NG; Nguyen PP; Dang H; Ali HA; Zhang N; Huang JF; Dai CY; Chuang WL; Roberts LR; Jun DW; Lim YS; Yu ML; Nguyen MH Aliment Pharmacol Ther; 2018 Jul; 48(1):44-54. PubMed ID: 29797518 [TBL] [Abstract][Full Text] [Related]
44. Comparable Mortality Between Asian Patients with Chronic Hepatitis B Under Long-Term Antiviral Therapy vs Matched Control: A Population-Based Study. Yun B; Oh J; Ahn SH; Yoon JH; Kim BK Am J Gastroenterol; 2023 Jun; 118(6):1001-1009. PubMed ID: 36288330 [TBL] [Abstract][Full Text] [Related]
45. Entecavir and Low Genetic Barrier Antiviral Agents for Hepatocellular Carcinoma in Hepatitis B Viral Cirrhosis: Propensity Score Matching. Li T; Qu Y; Wang Y; Lin C; Yang B; Wang L J Coll Physicians Surg Pak; 2019 Apr; 29(4):317-323. PubMed ID: 30925952 [TBL] [Abstract][Full Text] [Related]
46. Well-controlled viremia reduces the progression of hepatocellular carcinoma in chronic viral hepatitis patients treated with lenvatinib. Hsiao YW; Sou FM; Wang JH; Chen YH; Tsai MC; Hu TH; Hung CH; Chen CH; Kuo YH Kaohsiung J Med Sci; 2023 Dec; 39(12):1233-1242. PubMed ID: 37843189 [TBL] [Abstract][Full Text] [Related]
47. Comprehensive outcomes of on- and off-antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysis. An J; Shim JH; Kim SO; Choi J; Kim SW; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ J Med Virol; 2016 Sep; 88(9):1576-86. PubMed ID: 26945543 [TBL] [Abstract][Full Text] [Related]
48. Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus-related advanced fibrosis or cirrhosis. Kim BS; Seo YS; Kim YS; Lee CH; Lee HA; Um SH; Yoo JJ; Kim SG; Suh SJ; Jung YK; Ahn SH; Han KH; Yim HJ; Kim SU; J Gastroenterol Hepatol; 2018 Feb; 33(2):503-510. PubMed ID: 28666070 [TBL] [Abstract][Full Text] [Related]
49. Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease. Lee JM; Wei SC; Lee KM; Ye BD; Mao R; Kim HS; Park SJ; Park SH; Oh EH; Im JP; Jang BI; Kim DB; Takeuchi K Gut Liver; 2022 May; 16(3):396-403. PubMed ID: 34593670 [TBL] [Abstract][Full Text] [Related]
50. Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity. Kim MN; Kim BK; Cho H; Goh MJ; Roh YH; Yu SJ; Sinn DH; Park SY; Kim SU PLoS One; 2024; 19(8):e0307712. PubMed ID: 39186715 [TBL] [Abstract][Full Text] [Related]
51. Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma. Sohn W; Kang TW; Choi SK; Jung SH; Lee MW; Lim HK; Cho JY; Shim SG; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Rhim H; Paik YH Oncotarget; 2016 Jul; 7(30):47794-47807. PubMed ID: 27329596 [TBL] [Abstract][Full Text] [Related]
52. Efficacy of antiviral prophylaxis in HBsAg-negative, anti-HBc positive patients undergoing hematopoietic stem cell transplantation. Yoo JJ; Cho EJ; Cho YY; Lee M; Lee DH; Cho Y; Lee JH; Yu SJ; Yoon SS; Yoon JH; Kim YJ Liver Int; 2015 Dec; 35(12):2530-6. PubMed ID: 26053357 [TBL] [Abstract][Full Text] [Related]
53. High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study. Yang T; Lu JH; Zhai J; Lin C; Yang GS; Zhao RH; Shen F; Wu MC Eur J Surg Oncol; 2012 Aug; 38(8):683-91. PubMed ID: 22621971 [TBL] [Abstract][Full Text] [Related]
54. Effects of TACE and preventive antiviral therapy on HBV reactivation and subsequent hepatitis in hepatocellular carcinoma: a meta-analysis. Zhang SS; Liu JX; Zhu J; Xiao MB; Lu CH; Ni RZ; Qu LS Jpn J Clin Oncol; 2019 Jul; 49(7):646-655. PubMed ID: 30968933 [TBL] [Abstract][Full Text] [Related]
55. A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib. Yang Y; Wen F; Li J; Zhang P; Yan W; Hao P; Xia F; Bi F; Li Q Liver Int; 2015 Sep; 35(9):2147-54. PubMed ID: 25676812 [TBL] [Abstract][Full Text] [Related]
56. Entecavir and tenofovir reduce hepatitis B virus-related hepatocellular carcinoma recurrence more effectively than other antivirals. Cho H; Ahn H; Lee DH; Lee JH; Jung YJ; Chang Y; Nam JY; Cho YY; Lee DH; Cho EJ; Yu SJ; Lee JM; Kim YJ; Yoon JH J Viral Hepat; 2018 Jun; 25(6):707-717. PubMed ID: 29316069 [TBL] [Abstract][Full Text] [Related]
57. Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative. Wang K; Jiang G; Jia Z; Zhu X; Ni C Medicine (Baltimore); 2018 Jun; 97(22):e10940. PubMed ID: 29851833 [TBL] [Abstract][Full Text] [Related]
58. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation. Lee EC; Kim SH; Lee SD; Park H; Lee SA; Park SJ World J Gastroenterol; 2016 Apr; 22(14):3803-12. PubMed ID: 27076765 [TBL] [Abstract][Full Text] [Related]
59. Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib. Lim S; Han J; Kim GM; Han KH; Choi HJ J Gastroenterol Hepatol; 2015 Jun; 30(6):1024-31. PubMed ID: 25611175 [TBL] [Abstract][Full Text] [Related]
60. HBV reactivation and its effect on survival in HBV-related hepatocarcinoma patients undergoing transarterial chemoembolization combined with tyrosine kinase inhibitors plus immune checkpoint inhibitors. Shen J; Wang X; Wang N; Wen S; Yang G; Li L; Fu J; Pan X Front Cell Infect Microbiol; 2023; 13():1179689. PubMed ID: 37197205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]